Stock Market News
Allergan rows back on talk of Shire bid after shares drop
(WebFG News) - US pharma giant Allergan has pulled back from tabling a bid for UK-listed rival Shire just hours after first indicating its possible interest.
Invoking requirements under the UK Takeover Code, the Dublin-based outfit said it did not intend to make an offer, adding that it was continuing to examine the "full range" of strategic options at its disposal, including divestitures, combinations and acquisitions.
Initial reports that it might wade into the fray for Shire, earlier in the session, had seen the company's share price dive by just under 9%.
Shire shares were down 4.4% to below 3,800p on Friday afternoon, compared to Takeda's shares and cash offer of 4,650p.
"Shire's rejection of Takeda's bid likely came as no surprise to Takeda," said Credit Suisse analysts, and that Shire is probably now prepared to reconsider Takeda's pitch.
"With Allergan out of the picture, Takeda and Shire say they are continuing discussions regarding a potential offer, and we now see an increased likelihood of the pair reaching an agreement."
Based on recent takeover multiples, Societe Generale suggested Takeda could raise its cash component by another £9 per Shire share. "But we suspect that the Shire share price discounts otherwise because of Takeda's credit rating and/or dividend commitments."
Dismissing other potential suitors, as neither Novartis nor AbbVie are felt to "strategically need" Shire and that Pfizer is "no longer interested in transformational M&A", while Celgene and Allergan would have to raise so much new equity as to "excessively dilute" their earnings.
UBS think "it is more likely than not a deal gets done, but who precisely does the deal remains murky" as Takeda could increase the cash component of its offer but it will be "a real financial stretch".
"We think Shire investors are keen to avoid the regret they might feel if they don't sell and then the stock does badly. Regret avoidance can be a powerful motivator."
Invoking requirements under the UK Takeover Code, the Dublin-based outfit said it did not intend to make an offer, adding that it was continuing to examine the "full range" of strategic options at its disposal, including divestitures, combinations and acquisitions.
Initial reports that it might wade into the fray for Shire, earlier in the session, had seen the company's share price dive by just under 9%.
Shire shares were down 4.4% to below 3,800p on Friday afternoon, compared to Takeda's shares and cash offer of 4,650p.
"Shire's rejection of Takeda's bid likely came as no surprise to Takeda," said Credit Suisse analysts, and that Shire is probably now prepared to reconsider Takeda's pitch.
"With Allergan out of the picture, Takeda and Shire say they are continuing discussions regarding a potential offer, and we now see an increased likelihood of the pair reaching an agreement."
Based on recent takeover multiples, Societe Generale suggested Takeda could raise its cash component by another £9 per Shire share. "But we suspect that the Shire share price discounts otherwise because of Takeda's credit rating and/or dividend commitments."
Dismissing other potential suitors, as neither Novartis nor AbbVie are felt to "strategically need" Shire and that Pfizer is "no longer interested in transformational M&A", while Celgene and Allergan would have to raise so much new equity as to "excessively dilute" their earnings.
UBS think "it is more likely than not a deal gets done, but who precisely does the deal remains murky" as Takeda could increase the cash component of its offer but it will be "a real financial stretch".
"We think Shire investors are keen to avoid the regret they might feel if they don't sell and then the stock does badly. Regret avoidance can be a powerful motivator."
Related share prices |
---|
Shire Plc (SHP) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price